
OR-449 for Adrenocortical Carcinoma Earns Rare Pediatric Disease Designation
Rare Pediatric Disease designation (RPDD) is granted by the U.S. Food and Drug Administration (FDA) to drugs or biologics in development for rare pediatric diseases. In the United States, “rare”…